Urine Drug Testing for Opioid Use in Workers’ Compensation Cases

As prescription opioid use continues to rise, it becomes even more important for workers’ compensation organizations to implement programs to effectively treat and monitor claimants on chronic opioid therapy.
To receive your complimentary white paper, fill out the form to the right.

We invite you to download “Urine Drug Testing for Opioid Use in Workers’ Compensation Cases”, which was developed to provide you with greater insights into managing patient populations that include claimants taking opioids.

This white paper includes information on:

  • Trends in opioid use, as well as possible misuse, abuse and diversion
  • The role opioids play in proper pain management
  • The cost burden of opioids and opportunities to manage those costs
  • Guidelines for managing patients on chronic opioid therapy
  • Urine drug monitoring as a means to manage a patient population

Accreditations

CAP CLIA

Please fill out the form below to
Receive your complimentary white paper





All fields are required.